Related Experiment Video

Updated: Aug 16, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial

Gunamani Sithanandam1, George T Smith, Janet R Fields

  • 1Basic Research Program, SAIC-Frederick, Frederick, Maryland 21702, USA. sithanan@ncifcrf.gov

American Journal of Respiratory Cell and Molecular Biology
|August 2, 2005
PubMed

Insights

Epidermal growth factor receptor (EGFR) pathways control lung cell growth. Alternate pathways involving Gab1 and Shp2 are activated by TGF-alpha in non-transformed lung cells, unlike malignant cells.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • The epidermal growth factor receptor (EGFR) pathway, including ErbB2, ErbB3, PI3K, Akt, GSK3-beta, and cyclin D1, is crucial for lung adenocarcinoma cell growth, survival, and invasiveness.
  • Understanding these pathways in both normal and cancerous lung cells is vital for targeted therapies.

Purpose of the Study:

  • To investigate the EGFR signaling pathway in paired transformed and non-transformed murine lung epithelial cell lines.
  • To identify differences in pathway activation and key molecular players between malignant and non-malignant lung cells.

Main Methods:

  • Utilized paired murine lung epithelial cell lines (E9/E10 and A5/C10), representing transformed and non-transformed states.
  • Stimulated cells with transforming growth factor-alpha (TGF-alpha) and analyzed downstream signaling events.
  • Investigated protein complex formation, receptor expression, and cell cycle regulation using molecular biology techniques.

Main Results:

  • Transformed cells (E9, A5) expressed ErbB3 and TGF-alpha, responding to TGF-alpha with PI3K/Akt activation and increased cyclin D1.
  • Non-transformed cells (E10, C10) lacked ErbB3 and TGF-alpha but still activated PI3K/Akt and increased cyclin D1 upon TGF-alpha exposure.
  • A distinct pathway involving EGFR, Grb2, Gab1, and Shp2 was identified and prominent in non-transformed cells, with Gab1 highly expressed in these cells but not in malignant ones.

Conclusions:

  • Alternate signaling pathways downstream of EGFR regulate mitosis in malignant versus non-transformed lung cells.
  • Gab1 and Shp2 play a significant role in mediating EGFR-driven proliferation in non-transformed lung epithelial cells.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...